Save the NIH from Sequestration

A biomedical advocacy group asks Congress to protect the National Institutes of Health from the $2.5 billion cut that may be coming down the pike.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, POCO A POCOIf Congress fails to approve a plan to reduce the federal budget deficit by 1.2 trillion before January 2, 2013, federal agencies, including those responsible for funding life science researchers, will suffer automatic budget cuts—known as “sequestration”.

With that prospect looming, the California Healthcare Institute (CHI)—a non-profit advocacy group for the state’s biomedical research industry—has pleaded with Congress to ringfence the estimated $2.5 billion that would be slashed from the National Institutes of Health (NIH) budget. Such a reduction would seriously damage the Californian economy and compromise scientific innovation across the United States, the CHI argues in a letter addressed to political leaders of both parties.

The CHI also stated that the success of California's life science industry—which employs some 270,000 workers, pays more than $20 billion in wages every year, and accounts for $18.6 billion in global exports, according to the CHI letter—is the result of a combination of funding from the NIH and venture capitalists. Sequestration puts that partnership at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies